{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:11:25Z","timestamp":1788477085508,"version":"build-2803163510"},"reference-count":301,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Autoimmune diabetes is a disease characterized by the selective destruction of insulin-secreting \u03b2-cells of the endocrine pancreas by islet-reactive T cells. Autoimmune disease requires a complex interplay between host genetic factors and environmental triggers that promote the activation of such antigen-specific T lymphocyte responses. Given the critical involvement of self-reactive T lymphocyte in diabetes pathogenesis, understanding how these T lymphocyte populations contribute to disease is essential to develop targeted therapeutics. To this end, several key antigenic T lymphocyte epitopes have been identified and studied to understand their contributions to disease with the aim of developing effective treatment approaches for translation to the clinical setting. In this review, we discuss the role of pathogenic islet-specific T lymphocyte responses in autoimmune diabetes, the mechanisms and cell types governing autoantigen presentation, and therapeutic strategies targeting such T lymphocyte responses for the amelioration of disease.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1440045","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:49:04Z","timestamp":1723697344000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Antigen-specific T cell responses in autoimmune diabetes"],"prefix":"10.3389","volume":"15","author":[{"given":"Alexander J.","family":"Dwyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary R.","family":"Shaheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Fife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12597","article-title":"Genetics of type 1 diabetes","volume":"19","author":"Redondo","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3245.Fine","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a007732","article-title":"Genetics of type 1 diabetes","volume":"2","author":"Noble","year":"2012","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a006957","article-title":"T-cell tolerance: central and peripheral","volume":"4","author":"Xing","year":"2012","journal-title":"Cold Spring Harbor Perspect Biol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/BF00274777","article-title":"The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins","volume":"31","author":"Olmos","year":"1988","journal-title":"Diabetologia"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.10.1176","article-title":"Late progression to diabetes and evidence for chronic \u03b2-cell autoimmunity in identical twins of patients with type I diabetes","volume":"44","author":"Verge","year":"1995","journal-title":"Diabetes"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0805398","article-title":"Concordance for islet autoimmunity among monozygotic twins","volume":"359","author":"Redondo","year":"2008","journal-title":"New Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051626","article-title":"Heterogeneity of Type I diabetes: Analysis of monozygotic twins in Great Britain and the United States","volume":"44","author":"Redondo","year":"2001","journal-title":"Diabetologia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.4.1052","article-title":"Genetic liability of type 1 diabetes and the onset age among 22,650 young finnish twin pairs","volume":"52","author":"Hyttinen","year":"2003","journal-title":"Diabetes"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051614","article-title":"The role of viruses in Type I diabetes: Two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals","volume":"44","author":"Jun","year":"2001","journal-title":"Diabetologia"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9071519","article-title":"Viruses and type 1 diabetes: from enteroviruses to the virome","volume":"9","author":"Isaacs","year":"2021","journal-title":"Microorganisms"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-042320-015952","article-title":"Enteroviruses and type 1 diabetes: multiple mechanisms and factors","volume":"73","author":"Lloyd","year":"2022","journal-title":"Annu Rev Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d35","article-title":"Enterovirus infection and type 1 diabetes mellitus: Systematic review and meta-analysis of observational molecular studies","volume":"342","author":"Yeung","year":"2011","journal-title":"BMJ"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1370","article-title":"Detection of a low-grade enteroviral infection in the islets of langerhans of living patients newly diagnosed with type 1 diabetes","volume":"64","author":"Krogvold","year":"2015","journal-title":"Diabetes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197905243002102","article-title":"Isolation of a virus from the pancreas of a child with diabetic ketoacidosis","volume":"300","author":"Yoon","year":"1979","journal-title":"New Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.5.708","article-title":"Acceleration of type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets","volume":"49","author":"Serreze","year":"2000","journal-title":"Diabetes"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/science.162.3856.913","article-title":"Diabetes mellitus: induction in mice by encephalomyocarditis virus","volume":"162","author":"Craighead","year":"2022","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4161\/viru.20573","article-title":"The encephalomyocarditis virus","volume":"3","author":"Carocci","year":"2012","journal-title":"Virulence"},{"key":"B20","volume-title":"Induction of Type I Diabetes by Kilham ' s Rat Virus in Diabetes-Resistant BB \/ Wor Rats","author":"Guberski","year":"1991"},{"key":"B21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.2012.06826.x","article-title":"The role of reactive oxygen species and proinflammatory cytokines in type 1 diabetes pathogenesis","volume":"1281","author":"Padgett","year":"2013","journal-title":"Ann New York Acad Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/biom5031938","article-title":"Macrophage expression of inflammatory genes in response to EMCV infection","volume":"5","author":"Shaheen","year":"2015","journal-title":"Biomolecules"},{"key":"B23","article-title":"The response of the lymphatic tissue to the microbial flora. Studies on germfree mice","volume":"42","author":"Bauer","year":"1963","journal-title":"Am J Pathol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1831-2","article-title":"Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse","volume":"48","author":"Calcinaro","year":"2005","journal-title":"Diabetologia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2564-7","article-title":"Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse","volume":"55","author":"Hansen","year":"2012","journal-title":"Diabetologia"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0125448","article-title":"Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes","volume":"10","author":"Candon","year":"2015","journal-title":"PloS One"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500884","article-title":"Maternal antibiotic treatment protects offspring from diabetes development in nonobese diabetic mice by generation of tolerogenic APCs","volume":"195","author":"Hu","year":"2015","journal-title":"J Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0526","article-title":"Fecal microbiota composition differs between children with \u03b2-cell autoimmunity and those without","volume":"62","author":"De Goffau","year":"2013","journal-title":"Diabetes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0025792","article-title":"Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes","volume":"6","author":"Brown","year":"2011","journal-title":"PloS One"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00678","article-title":"Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes","volume":"5","author":"Davis-Richardson","year":"2014","journal-title":"Front Microbiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3274-0","article-title":"Aberrant gut microbiota composition at the onset of type 1 diabetes in young children","volume":"57","author":"De Goffau","year":"2014","journal-title":"Diabetologia"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1086\/203459","article-title":"The dynamics of the human infant gut microbiome in development and in progression towards type 1 diabetes","volume":"17","author":"Kostic","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1560-1","article-title":"Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth","volume":"574","author":"Shao","year":"2019","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-0941-z","article-title":"Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: A meta-analysis of observational studies","volume":"51","author":"Cardwell","year":"2008","journal-title":"Diabetologia"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400085","article-title":"Mode of delivery shapes gut colonization pattern and modulates regulatory immunity in mice","volume":"193","author":"Hansen","year":"2014","journal-title":"J Immunol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20160526","article-title":"Microbial antigen mimics activate diabetogenic CD8 T cells in NOD mice","volume":"213","author":"Tai","year":"2016","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2015.1011876","article-title":"Gut microbial markers are associated with diabetes onset, regulatory imbalance, and IFN-\u03b3 level in NOD Mice","volume":"6","author":"Krych","year":"2015","journal-title":"Gut Microbes"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1130","article-title":"Infant feeding in relation to islet autoimmunity and type 1 diabetes in genetically susceptible children: The MIDIA study","volume":"38","author":"Lund-Blix","year":"2015","journal-title":"Diabetes Care"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-0016","article-title":"Infant feeding and risk of type 1 diabetes in two large scandinavian birth cohorts","volume":"40","author":"Lund-Blix","year":"2017","journal-title":"Diabetes Care"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2003.09.012","article-title":"Delayed exposure to wheat and barley proteins reduces diabetes incidence in non-obese diabetic mice","volume":"111","author":"Schmid","year":"2004","journal-title":"Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1297\/cpe.7.125","article-title":"Coeliac disease in children and adolescents with type 1 diabetes mellitus: to screen or not, to treat or not","volume":"57","author":"Schober","year":"2002","journal-title":"Hormone Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.k3547","article-title":"Association between maternal gluten intake and type 1 diabetes in offspring: national prospective cohort study in Denmark","volume":"362","author":"Antvorskov","year":"2018","journal-title":"BMJ"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1721","article-title":"Early infant feeding and risk of developing type 1 diabetes-Associated autoantibodies","volume":"290","author":"Ziegler","year":"2003","journal-title":"J Am Med Assoc"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.13.1713","article-title":"Timing of initial cereal exposure in infancy and risk of islet autoimmunity","volume":"290","author":"Norris","year":"2003","journal-title":"J Am Med Assoc"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021177","article-title":"Six months of gluten-free diet do not influence autoantibody titers, but improve insulin secretion in subjects at high risk for type 1 diabetes","volume":"88","author":"Pastore","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1900\/RDS.2004.1.39","article-title":"Elimination of dietary gluten and development of type 1 diabetes in high risk subjects","volume":"1","author":"Fuchtenbusch","year":"2004","journal-title":"Rev Diabetic Stud"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1538\/expanim1978.29.1_1","article-title":"Breeding of a non-obese, diabetic strain of mice","volume":"29","author":"Makino","year":"1980","journal-title":"Jikken dobutsu. Exp Anim"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(93)90160-M","article-title":"NOD mouse colonies around the world - recent facts and figures","volume":"14","author":"Pozzilli","year":"1993","journal-title":"Immunol Today"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115643","article-title":"The NOD mouse: A model of immune dysregulation","volume":"23","author":"Anderson","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaut.2015.08.019","article-title":"The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes","volume":"66","author":"Pearson","year":"2016","journal-title":"J Autoimmun"},{"key":"B52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jaut.2004.04.002","article-title":"Precursor frequencies of T-cells reactive to insulin in recent onset type 1 diabetes mellitus","volume":"23","author":"Naik","year":"2004","journal-title":"J Autoimmun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nature03523","article-title":"Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice","volume":"435","author":"Nakayama","year":"2005","journal-title":"Nature"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2009.04.013.Changes","article-title":"Changes in autoreactive T cell avidity during type 1 diabetes development","volume":"132","author":"Standifer","year":"2009","journal-title":"Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.04.008","article-title":"Molecular targeting of islet autoantigens","volume":"32","author":"Stadinski","year":"2010","journal-title":"Immunity"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1006545107","article-title":"Diabetogenic T cells recognize insulin bound to IAg7 in an unexpected, weakly binding register","volume":"107","author":"Stadinski","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1844","article-title":"Chromogranin A is an autoantigen in type 1 diabetes","volume":"11","author":"Stadinski","year":"2010","journal-title":"Nat Immunol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J Exp Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301480","article-title":"Cutting Edge: CD4 T cells reactive to an IAPP peptide accumulate in the pancreas and contribute to disease pathogenesis in NOD mice","volume":"191","author":"Baker","year":"2013","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94549","article-title":"Autoreactive T cells in type 1 diabetes","volume":"127","author":"Pugliese","year":"2017","journal-title":"J Clin Invest"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.148221","article-title":"Genetics of type 1 diabetes","volume":"57","author":"Steck","year":"2011","journal-title":"Clin Chem"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25350","article-title":"Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity","volume":"115","author":"Suri","year":"2005","journal-title":"J Clin Invest"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.7.3635","article-title":"Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7","volume":"168","author":"Wen","year":"2002","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.4135\/9781412963954.n6","article-title":"Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes","volume":"240","author":"Shizuru","year":"1988","journal-title":"Science"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.10.5708","article-title":"Isolation of self antigen-reactive cells from inflamed islets of nonobese diabetic mice using CD4high expression as a marker","volume":"163","author":"Lejon","year":"1999","journal-title":"J Immunol"},{"key":"B66","author":"Wegmann","year":"1994"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250430","article-title":"Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice","volume":"25","author":"Daniel","year":"1995","journal-title":"Eur J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.02.003","article-title":"Analysis of T cell receptor beta chains that combine with dominant conserved TRAV5D-4*04 anti-insulin B:9\u201323 alpha chains","volume":"33","author":"Zhang","year":"2009","journal-title":"J Autoimmun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1288.027","article-title":"Establishing insulin 1 and insulin 2 knockout congenic strains on NOD genetic background","volume":"1005","author":"Paronen","year":"2003","journal-title":"Ann New York Acad Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1337.031","article-title":"Establishment of native insulin-negative NOD mice and the methodology to distinguish specific insulin knockout genotypes and a B:16 alanine preproinsulin transgene","volume":"1037","author":"Nakayama","year":"2004","journal-title":"Ann New York Acad Sci"},{"key":"B71","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S1074-7613(00)80220-4","article-title":"Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice","volume":"12","author":"Latek","year":"2000","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.288.5465.505\/SUPPL_FILE\/1049210S3_THUMB.GIF","article-title":"A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes","volume":"288","author":"Corper","year":"2000","journal-title":"Science"},{"key":"B73","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/329599a0","article-title":"HLA-DQ\u03b2 gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus","volume":"329","author":"Todd","year":"1987","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6051","article-title":"The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form","volume":"178","author":"Levisetti","year":"2007","journal-title":"J Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41502","article-title":"The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity","volume":"120","author":"Yoshida","year":"2010","journal-title":"J Clin Invest"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1126\/SCIIMMUNOL.AAW6329\/SUPPL_FILE\/AAW6329_TABLE_S3.XLSX","article-title":"Position \u03b257 of I-Ag7 controls early anti-insulin responses in NOD mice, linking an MHC susceptibility allele to type 1 diabetes onset","volume":"4","author":"Gioia","year":"2019","journal-title":"Sci Immunol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130582","article-title":"Pathogenic CD4+ T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes","volume":"210","author":"Mohan","year":"2013","journal-title":"J Exp Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20111502","article-title":"Register shifting of an insulin peptide\u2013MHC complex allows diabetogenic T cells to escape thymic deletion","volume":"208","author":"Mohan","year":"2011","journal-title":"J Exp Med"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1850","article-title":"Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes","volume":"11","author":"Mohan","year":"2010","journal-title":"Nat Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1113954108","article-title":"Specificity and detection of insulin-reactive CD4+ T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse","volume":"108","author":"Crawford","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1716527115","article-title":"C-terminal modification of the insulin B:11\u201323 peptide creates superagonists in mouse and human type 1 diabetes","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciimmunol.aav7517","article-title":"How C-terminal additions to insulin B-chain fragments create super-agonists for T cells in mouse and human type 1 diabetes","volume":"4","author":"Wang","year":"2019","journal-title":"Sci Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.1416864111\/-\/DCSUPPLEMENTAL","article-title":"Autoreactive T cells specific for insulin B:11\u201323 recognize a low-affinity peptide register in human subjects with autoimmune diabetes","volume":"111","author":"Yang","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20110574","article-title":"Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope","volume":"208","author":"Daniel","year":"2011","journal-title":"J Exp Med"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1323436111","article-title":"Monoclonal antibody blocking the recognition of an insulin peptide\u2013MHC complex modulates type 1 diabetes","volume":"111","author":"Zhang","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/347151a0","article-title":"Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase","volume":"347","author":"Baekkeskov","year":"1990","journal-title":"Nature"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2337\/diab.42.12.1799","article-title":"Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets","volume":"42","author":"Kim","year":"1993","journal-title":"Diabetes"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112903","article-title":"Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes","volume":"79","author":"Baekkeskov","year":"1987","journal-title":"J Clin Invest"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116192","article-title":"Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes","volume":"91","author":"Atkinson","year":"1993","journal-title":"J Clin Invest"},{"key":"B90","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgab816","article-title":"Autoantibodies to N-terminally truncated GAD65(96\u2013585): HLA associations and predictive value for type 1 diabetes","volume":"107","author":"Pollanen","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.8.1987","article-title":"GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes","volume":"53","author":"Reijonen","year":"2004","journal-title":"Diabetes"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.8.1390","article-title":"Detection of GAD65-reactive T-cells in type 1 diabetes by immunoglobulin-free ELISPOT assays","volume":"25","author":"Kotani","year":"2002","journal-title":"Diabetes Care"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5417.1183","article-title":"Control of autoimmune diabetes in NOD mice by GAD expression or suppression in \u03b2 cells","volume":"284","author":"Yoon","year":"1999","journal-title":"Science"},{"key":"B94","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s002510050238","article-title":"Identification of immunogenic epitopes of GAD 65 presented by Ag7 in non-obese diabetic mice","volume":"46","author":"Chao","year":"1997","journal-title":"Immunogenetics"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.22.12970","article-title":"The role of MHC class II molecules in susceptibility to type I diabetes: Identification of peptide epitopes and characterization of the T cell repertoire","volume":"96","author":"Chao","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B96","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/366069a0.Spontaneous","article-title":"Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes","volume":"366","author":"Kaufman","year":"1993","journal-title":"Nature"},{"key":"B97","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1172\/JCI119878","article-title":"GAD-reactive CD4+ Th1 cells induce diabetes in NOD\/SCID mice","volume":"101","author":"Zekzer","year":"1998","journal-title":"J Clin Invest"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1994.1048","article-title":"Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide","volume":"7","author":"Chen","year":"1994","journal-title":"J Autoimmun"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1996.0048","article-title":"Peripheral T cell clones from NOD mice specific for GAD65 peptides: Lack of islet responsiveness or diabetogenicity","volume":"9","author":"Schloot","year":"1996","journal-title":"J Autoimmun"},{"key":"B100","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0896\u20138411(03)00003\u20139","article-title":"An islet-homing NOD CD8+ cytotoxic T cell clone recognizes GAD65 and causes insulitis","volume":"20","author":"Videb\u00e6k","year":"2003","journal-title":"J Autoimmun"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118188","article-title":"Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512)","volume":"96","author":"Payton","year":"1995","journal-title":"J Clin Invest"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.10.1344","article-title":"Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512\/IA-2","volume":"45","author":"Kawasaki","year":"1996","journal-title":"Diabetes"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"Jama"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.3.356","article-title":"T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetes","volume":"49","author":"Hawkes","year":"2000","journal-title":"Diabetes"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0131","article-title":"Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct","volume":"60","author":"Howson","year":"2011","journal-title":"Diabetes"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-2088","article-title":"Age of islet autoantibody appearance and mean levels of insulin, but not GAD or IA-2 autoantibodies, predict age of diagnosis of type 1 diabetes: diabetes autoimmunity study in the young","volume":"34","author":"Steck","year":"2011","journal-title":"Diabetes Care"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-04975-x","article-title":"What has zinc transporter 8 autoimmunity taught us about type 1 diabetes","volume":"62","author":"Williams","year":"2019","journal-title":"Diabetologia"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.772152","article-title":"Coupling of insulin secretion and display of a granule-resident zinc transporter znT8 on the surface of pancreatic beta cells","volume":"292","author":"Huang","year":"2017","journal-title":"J Biol Chem"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0705894104","article-title":"The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes","volume":"104","author":"Wenzlau","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-2081","article-title":"Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies","volume":"35","author":"Yu","year":"2012","journal-title":"Diabetes Care"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003815","article-title":"Human type 1 diabetes is associated with T cell autoimmunity to zinc transporter 8","volume":"186","author":"Dang","year":"2011","journal-title":"J Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2540-2","article-title":"Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases","volume":"55","author":"Howson","year":"2012","journal-title":"Diabetologia"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aao4013","article-title":"Islet-reactive CD8(+) T cell frequencies in the pancreas, but not in blood, distinguish type 1 diabetic patients from healthy donors","volume":"3","author":"Culina","year":"2018","journal-title":"Sci Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1882","article-title":"ZnT8-reactive T cells are weakly pathogenic in NOD mice but can participate in diabetes under inflammatory conditions","volume":"63","author":"Nayak","year":"2014","journal-title":"Diabetes"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0932778100","article-title":"Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes","volume":"100","author":"Lieberman","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.152.4.2042","article-title":"Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic \u03b2-cells in nonobese diabetic mice","volume":"152","author":"Nagata","year":"1994","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.8.1121","article-title":"Major histocompatibility complex class I\u2013restricted infiltration and destruction of pancreatic islets by NOD mouse-derived \u03b2-cell cytotoxic CD8+ T-cell clones in vivo","volume":"45","author":"Utsugi","year":"1996","journal-title":"Diabetes"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.154.5.2494","article-title":"Beta-cell-cytotoxic CD8+ T cells from nonobese diabetic mice use highly homologous T cell receptor \u03b1-chain CDR3 sequences","volume":"154","author":"Santamaria","year":"1995","journal-title":"J Immunol"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.10.4726","article-title":"Acceleration of spontaneous diabetes in TCR-\u03b2-transgenic nonobese diabetic mice by \u03b2-cell cytotoxic CD8+ T cells expressing identical endogenous TCR-\u03b1 chains","volume":"157","author":"Verdaguer","year":"1996","journal-title":"J Immunol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.10.1663","article-title":"Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice","volume":"186","author":"Verdaguer","year":"1997","journal-title":"J Exp Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2337\/diabetes.48.1.34","article-title":"Absolute requirement of macrophages for the development and activation of \u03b2-cell cytotoxic CD8+ T-cells in T-cell receptor transgenic NOD mice","volume":"48","author":"Jun","year":"1999","journal-title":"Diabetes"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29602","article-title":"Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP","volume":"116","author":"Krishnamurthy","year":"2006","journal-title":"J Clin Invest"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1038\/nm1250","article-title":"Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide","volume":"11","author":"Han","year":"2005","journal-title":"Nat Med"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2014.29","article-title":"Functional cytotoxic T lymphocytes against IGRP206\u2013214 predict diabetes in the non-obese diabetic mouse","volume":"92","author":"Ko","year":"2014","journal-title":"Immunol Cell Biol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.5.3257","article-title":"HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes","volume":"176","author":"Takaki","year":"2006","journal-title":"J Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2008.01.015","article-title":"Identification of novel IGRP epitopes targeted in type 1 diabetes patients","volume":"127","author":"Jarchum","year":"2008","journal-title":"Clin Immunol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/srep44661","article-title":"CD8+ T cells specific for the islet autoantigen IGRP are restricted in their T cell receptor chain usage","volume":"7","author":"Fuchs","year":"2017","journal-title":"Sci Rep"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.2337\/db06-1419","article-title":"CD8+ T-cell responses identify \u03b2-cell autoimmunity in human type 1 diabetes","volume":"56","author":"Mallone","year":"2007","journal-title":"Diabetes"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.5.2781","article-title":"Islet-specific glucose-6-phosphatase catalytic subunit-related protein-reactive CD4+ T cells in human subjects","volume":"176","author":"Yang","year":"2006","journal-title":"J Immunol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1510409","article-title":"Occurrence of WE-14 and chromogranin A-derived peptides in tissues of the human and bovine gastro-entero-pancreatic system and in human neuroendocrine neoplasia","volume":"151","author":"Gleeson","year":"1996","journal-title":"J Endocrinol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.regpep.2008.07.005","article-title":"The importance of chromogranin A in the development and function of endocrine pancreas","volume":"151","author":"Portela-Gomes","year":"2008","journal-title":"Regul peptides"},{"key":"B132","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00441-017-2580-5","article-title":"Chromogranin A regulates vesicle storage and mitochondrial dynamics to influence insulin secretion","volume":"368","author":"Wollam","year":"2017","journal-title":"Cell Tissue Res"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0513","article-title":"Chromogranin A deficiency confers protection from autoimmune diabetes via multiple mechanisms","volume":"70","author":"Srivastava","year":"2021","journal-title":"Diabetes"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.10.1444","article-title":"T-lymphocyte clone specific for pancreatic islet antigen","volume":"37","author":"Haskins","year":"1988","journal-title":"Diabetes"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.20.8000","article-title":"Pancreatic islet-specific T-cell clones from nonobese diabetic mice","volume":"86","author":"Haskins","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1126\/science.2205920","article-title":"Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone","volume":"249","author":"Haskins","year":"1990","journal-title":"Science"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.3.328","article-title":"Transfer of diabetes in the NOD-scid mouse by CD4 T-cell clones: Differential requirement for CD8 T-cells","volume":"45","author":"Peterson","year":"1996","journal-title":"Diabetes"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90730-E","article-title":"Following a diabetogenic T cell from genesis through pathogenesis","volume":"74","author":"Katz","year":"1993","journal-title":"Cell"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.2337\/db07-1129","article-title":"On the pathogenicity of autoantigen-specific T-cell receptors","volume":"57","author":"Burton","year":"2008","journal-title":"Diabetes"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.2.908","article-title":"Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice","volume":"166","author":"Judkowski","year":"2001","journal-title":"J Immunol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxf106","article-title":"Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones","volume":"14","author":"Yoshida","year":"2002","journal-title":"Int Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.8.4011","article-title":"Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides","volume":"170","author":"You","year":"2003","journal-title":"J Immunol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2337\/diab.43.2.197","article-title":"Islet-specific T-cell clones from the NOD mouse respond to \u03b2-granule antigen","volume":"43","author":"Bergman","year":"1994","journal-title":"Diabetes"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.2000.0377","article-title":"Biochemical characterization of a beta cell membrane fraction antigenic for autoreactive T cell clones","volume":"14","author":"Bergman","year":"2000","journal-title":"J Autoimmun"},{"key":"B145","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4049\/jimmunol.1501190","article-title":"Cutting edge: nonobese diabetic mice deficient in chromogranin A are protected from autoimmune diabetes","volume":"196","author":"Baker","year":"2016","journal-title":"J Immunol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaut.2013.10.003.Chromogranin","article-title":"Chromogranin A is a T cell antigen in human type 1 diabetes","volume":"50","author":"Gottlieb","year":"2014","journal-title":"J Autoimmun"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003617","article-title":"Cutting edge: vasostatin-1\u2013derived peptide chgA29\u201342 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice","volume":"186","author":"Nikoopour","year":"2011","journal-title":"J Immunol"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.5.1386","article-title":"A diabetes-associated T-cell autoantigen maps to a telomeric locus on mouse chromosome 6","volume":"92","author":"Dallas-Pedretti","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.153.6.2800","article-title":"Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice","volume":"153","author":"Peterson","year":"1994","journal-title":"J Immunol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.2337\/db11-0288","article-title":"Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells","volume":"60","author":"Delong","year":"2011","journal-title":"Diabetes"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4203","article-title":"Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes","volume":"22","author":"Babon","year":"2016","journal-title":"Nat Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad2791","article-title":"Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion","volume":"351","author":"Delong","year":"2016","journal-title":"Science"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.2337\/db18-0200","article-title":"CD4 T cells reactive to hybrid insulin peptides are indicators of disease activity in the NOD mouse","volume":"67","author":"Baker","year":"2018","journal-title":"Diabetes"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.2337\/DB19\u20130128\/-\/DC1","article-title":"Hybrid insulin peptides are autoantigens in type 1 diabetes","volume":"68","author":"Baker","year":"2019","journal-title":"Diabetes"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0620","article-title":"Hybrid insulin peptides are recognized by human T cells in the context of DRB1*04:01","volume":"69","author":"Arribas-Layton","year":"2020","journal-title":"Diabetes"},{"key":"B156","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-02763-y","article-title":"T cells specific for post-translational modifications escape intrathymic tolerance induction","volume":"9","author":"Raposo","year":"2018","journal-title":"Nat Commun"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.32.22321","article-title":"Isoaspartyl post-translational modification triggers autoimmune responses to self-proteins","volume":"274","author":"Mamula","year":"1999","journal-title":"J Biol Chem"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0112","article-title":"Diabetogenic T-cell clones recognize an altered peptide of chromogranin A","volume":"61","author":"Delong","year":"2012","journal-title":"Diabetes"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.4.603","article-title":"The intestinal T cell response to \u03b1-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase","volume":"191","author":"Arentz-Hansen","year":"2000","journal-title":"J Exp Med"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1517862112","article-title":"N-terminal additions to the WE14 peptide of chromogranin A create strong autoantigen agonists in type 1 diabetes","volume":"112","author":"Jin","year":"2015","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2016.10.007","article-title":"An insulin-IAPP hybrid peptide is an endogenous antigen for CD4 T cells in the non-obese diabetic mouse","volume":"78","author":"Wiles","year":"2017","journal-title":"J Autoimmun"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.2337\/db19-0399","article-title":"A hybrid insulin epitope maintains high 2D affinity for diabetogenic T cells in the periphery","volume":"69","author":"Liu","year":"2020","journal-title":"Diabetes"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7144","article-title":"The frequency of high avidity T cells determines the hierarchy of determinant spreading","volume":"166","author":"Tian","year":"2001","journal-title":"J Immunol"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.8b00875","article-title":"Identification of hybrid insulin peptides (HIPs) in mouse and human islets by mass spectrometry","volume":"18","author":"Aaron Wiles","year":"2019","journal-title":"J Proteome Res"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1038\/1941148a0","article-title":"Transpeptidation mechanism in blood clotting","volume":"194","author":"Lorand","year":"1962","journal-title":"Nature"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1038\/nature02240","article-title":"Immune recognition of a human renal cancer antigen through post-translational protein splicing","volume":"427","author":"Hanada","year":"2004","journal-title":"Nature"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1126\/SCIENCE.1095522\/SUPPL_FILE\/VIGNERON.SOM.PDF","article-title":"An antigenic peptide produced by peptide splicing in the proteasome","volume":"304","author":"Vigneron","year":"2004","journal-title":"Science"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/BF00266030","article-title":"The mechanism of insulin secretion","volume":"26","author":"Howell","year":"1984","journal-title":"Diabetologia"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.07.007","article-title":"Conventional and neo-antigenic peptides presented by \u03b2 Cells are targeted by circulating na\u00efve CD8+ T cells in type 1 diabetic and healthy donors","volume":"28","author":"Gonzalez-Duque","year":"2018","journal-title":"Cell Metab"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20192135","article-title":"Lysosomal cathepsin creates chimeric epitopes for diabetogenic CD4 T cells via transpeptidation","volume":"218","author":"Reed","year":"2021","journal-title":"J Exp Med"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1407406","article-title":"Distinct roles for cysteine cathepsin genes in multistage tumorigenesis","volume":"20","author":"Gocheva","year":"2006","journal-title":"Genes Dev"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0120348","article-title":"Deficiency for the cysteine protease cathepsin l impairs Myc-induced tumorigenesis in a mouse model of pancreatic neuroendocrine cancer","volume":"10","author":"Brindle","year":"2015","journal-title":"PloS One"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.2337\/DB12\u20131214\/-\/DC1","article-title":"Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes","volume":"63","author":"Van Lummel","year":"2014","journal-title":"Diabetes"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1952","article-title":"Recognition of posttranslationally modified GAD65 epitopes in subjects with type 1 diabetes","volume":"63","author":"McGinty","year":"2014","journal-title":"Diabetes"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4289","article-title":"Autoimmunity against a defective ribosomal insulin gene product in type 1 diabetes","volume":"23","author":"Kracht","year":"2017","journal-title":"Nat Med"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0200818","article-title":"Heterogeneity of circulating CD8 T-cells specific to islet, neo-antigen and virus in patients with type 1 diabetes mellitus","volume":"13","author":"Laban","year":"2018","journal-title":"PloS One"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pgen.1002552","article-title":"The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines","volume":"8","author":"Eizirik","year":"2012","journal-title":"PloS Genet"},{"key":"B178","doi-asserted-by":"publisher","first-page":"895","DOI":"10.2337\/diabetes.50.4.895","article-title":"Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen","volume":"50","author":"Diez","year":"2001","journal-title":"Diabetes"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1023\/B:JOCI.0000029120.77824.41","article-title":"T cells recognize multiple GAD65 and proinsulin epitopes in human type 1 diabetes, suggesting determinant spreading","volume":"24","author":"Ott","year":"2004","journal-title":"J Clin Immunol"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.8.5265","article-title":"Intermolecular antigen spreading occurs during the preclinical period of human type 1 diabetes","volume":"166","author":"Brooks-Worrell","year":"2001","journal-title":"J Immunol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2008.03860.x","article-title":"Analysis of islet inflammation in human type 1 diabetes","volume":"155","author":"Willcox","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.2337\/DB15\u20130779\/-\/DC1","article-title":"Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.04.005.Pathogenesis","article-title":"Pathogenesis of NOD diabetes is initiated by reactivity to the insulin B chain 9\u201323 epitope and involves functional epitope spreading","volume":"39","author":"Prasad","year":"2012","journal-title":"J Autoimmun"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061577","article-title":"Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway","volume":"203","author":"Fife","year":"2006","journal-title":"J Exp Med"},{"key":"B185","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00125-006-0569-9","article-title":"Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-\u03b1 in patients with recent-onset type 1 diabetes","volume":"50","author":"Uno","year":"2007","journal-title":"Diabetologia"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1713543114","article-title":"Resident macrophages of pancreatic islets have a seminal role in the initiation of autoimmune diabetes of NOD mice","volume":"114","author":"Carrero","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201141770","article-title":"Abnormalities of dendritic cell precursors in the pancreas of the NOD mouse model of diabetes","volume":"42","author":"Welzen-Coppens","year":"2012","journal-title":"Eur J Immunol"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0801973105","article-title":"Dendritic cells in islets of Langerhans constitutively present \u03b2 cell-derived peptides bound to their class II MHC molecules","volume":"105","author":"Calderon","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1515954112","article-title":"Beta cells transfer vesicles containing insulin to phagocytes for presentation to T cells","volume":"112","author":"Vomund","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0341-6","article-title":"Pancreatic islets communicate with lymphoid tissues via exocytosis of insulin peptides","volume":"560","author":"Wan","year":"2018","journal-title":"Nature"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20030966","article-title":"Physiological \u03b2 Cell death triggers priming of self-reactive T cells by dendritic cells in a type-1 diabetes model","volume":"198","author":"Turley","year":"2003","journal-title":"J Exp Med"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.09.012","article-title":"A minor subset of Batf3-dependent antigen presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes","volume":"41","author":"Ferris","year":"2014","journal-title":"Immunity"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8\u03b1+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.08.027","article-title":"Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells","volume":"31","author":"Dorner","year":"2009","journal-title":"Immunity"},{"key":"B195","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.7.989","article-title":"Evidence for initial involvement of macrophage in development of insulitis in NOD mice","volume":"37","author":"Lee","year":"1988","journal-title":"Diabetes"},{"key":"B196","doi-asserted-by":"publisher","DOI":"10.1038\/348639a0","article-title":"Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages","volume":"348","author":"Hutchings","year":"1990","journal-title":"Nature"},{"key":"B197","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20150496","article-title":"The pancreas anatomy conditions the origin and properties of resident macrophages","volume":"212","author":"Calderon","year":"2015","journal-title":"J Exp Med"},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4592-4","article-title":"The resident macrophages in murine pancreatic islets are constantly probing their local environment, capturing beta cell granules and blood particles","volume":"61","author":"Zinselmeyer","year":"2018","journal-title":"Diabetologia"},{"key":"B199","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"B200","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"B201","doi-asserted-by":"publisher","first-page":"R525","DOI":"10.1152\/ajpregu.00019.2019","article-title":"CCR5 is a required signaling receptor for macrophage expression of inflammatory genes in response to viral double-stranded RNA","volume":"316","author":"Shaheen","year":"2019","journal-title":"Am J Physiol Regulatory Integr Comp Physiol"},{"key":"B202","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA119.010267","article-title":"The location of sensing determines the pancreatic \u03b2-cell response to the viral mimetic dsRNA","volume":"295","author":"Shaheen","year":"2020","journal-title":"J Biol Chem"},{"key":"B203","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)54642-1","article-title":"Interleukin-1 beta-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. Role of nitric oxide in interleukin-1 beta-induced inhibition of insulin secretion","volume":"266","author":"Corbett","year":"1991","journal-title":"J Biol Chem"},{"key":"B204","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.2.559","article-title":"Intraislet release of interleukin 1 inhibits beta cell function by inducing beta cell expression of inducible nitric oxide synthase","volume":"181","author":"Corbett","year":"1995","journal-title":"J Exp Med"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.6.2684","article-title":"Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes","volume":"160","author":"Arnush","year":"1998","journal-title":"J Immunol"},{"key":"B206","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2017.7351","article-title":"Dual role of nitric oxide in regulating the response of beta cells to DNA damage","volume":"29","author":"Oleson","year":"2017","journal-title":"Antioxidants Redox Signaling"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.1172\/JCI844","article-title":"IL-1 produced and released endogenously within human islets inhibits beta cell function","volume":"102","author":"Arnush","year":"1998","journal-title":"J Clin Invest"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1210\/endo-129-6-3167","article-title":"Interleukin-1 beta-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase","volume":"129","author":"Welsh","year":"1991","journal-title":"Endocrinology"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(90)80502-A","article-title":"Inhibition of insulin secretion by interleukin-1 beta and tumour necrosis factor-alpha via an L-arginine-dependent nitric oxide generating mechanism","volume":"276","author":"Southern","year":"1990","journal-title":"FEBS Lett"},{"key":"B210","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.5.4024-4031.1997","article-title":"Possible role of macrophage-derived soluble mediators in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice","volume":"71","author":"Hirasawa","year":"1997","journal-title":"J Virol"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00205-09","article-title":"Role of nitric oxide in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice","volume":"83","author":"Lee","year":"2009","journal-title":"J Virol"},{"key":"B212","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.5.557","article-title":"Kilham rat triggers T-cell-dependent autoimmune diabetes in multiple strains of rat","volume":"45","author":"Ellerman","year":"1996","journal-title":"Diabetes"},{"key":"B213","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.2.1327","article-title":"Immunoregulatory role of nitric oxide in Kilham rat virus-induced autoimmune diabetes in DR-BB rats","volume":"173","author":"Mendez","year":"2004","journal-title":"J Immunol"},{"key":"B214","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.159.1.466","article-title":"Role of macrophages and macrophage-derived cytokines in the pathogenesis of Kilham rat virus-induced autoimmune diabetes in diabetes-resistant BioBreeding rats","volume":"159","author":"Chung","year":"1997","journal-title":"J Immunol"},{"key":"B215","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.2.347","article-title":"The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice","volume":"189","author":"Jun","year":"1999","journal-title":"J Exp Med"},{"key":"B216","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.85.16.6137","article-title":"Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in CD-1 mice","volume":"85","author":"Wright","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"B217","doi-asserted-by":"publisher","DOI":"10.2337\/diab.34.2.197","article-title":"Administration of silica prevents diabetes in BB-rats","volume":"34","author":"OsChilewski","year":"1985","journal-title":"Diabetes"},{"key":"B218","doi-asserted-by":"publisher","DOI":"10.1084\/jem.171.3.729","article-title":"Prevention of diabetes in the BB rat by essential fatty acid deficiency. Relationship between physiological and biochemical changes","volume":"171","author":"Lefkowith","year":"1990","journal-title":"J Exp Med"},{"key":"B219","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0059701","article-title":"Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse","volume":"8","author":"Carrero","year":"2013","journal-title":"PloS One"},{"key":"B220","doi-asserted-by":"publisher","DOI":"10.1084\/jem.184.5.2049","article-title":"B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: Analysis of a new \"speed congenic\" stock of NOD.Ig\u03bcnull mice","volume":"184","author":"Serreze","year":"1996","journal-title":"J Exp Med"},{"key":"B221","doi-asserted-by":"publisher","DOI":"10.2337\/diab.46.6.941","article-title":"B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice","volume":"46","author":"Noorchashm","year":"1997","journal-title":"Diabetes"},{"key":"B222","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/9.8.1159","article-title":"Direct evidence for the contribution of B cells to the progression of insulitis and the development of diabetes in non-obese diabetic mice","volume":"9","author":"Akashi","year":"1997","journal-title":"Int Immunol"},{"key":"B223","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.10.5535","article-title":"Cutting edge: B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice","volume":"167","author":"Hulbert","year":"2001","journal-title":"J Immunol"},{"key":"B224","doi-asserted-by":"publisher","DOI":"10.1002\/1521\u20134141(200212)32:12<3657::AID-IMMU3657>3.0.CO;2-E","article-title":"The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors","volume":"32","author":"Silveira","year":"2002","journal-title":"Eur J Immunol"},{"key":"B225","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1227133","article-title":"Novel engineered B lymphocytes targeting islet-specific T cells inhibit the development of type 1 diabetes in non-obese diabetic Scid mice","volume":"14","author":"Chen","year":"2023","journal-title":"Front Immunol"},{"key":"B226","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.2.680","article-title":"Dysregulated B7\u20131 and B7\u20132 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis","volume":"174","author":"Hussain","year":"2005","journal-title":"J Immunol"},{"key":"B227","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.2.743","article-title":"I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice","volume":"163","author":"Noorchashm","year":"1999","journal-title":"J Immunol"},{"key":"B228","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0006","article-title":"B-cell cross-presentation of autologous antigen precipitates diabetes","volume":"61","author":"Mari\u00f1o","year":"2012","journal-title":"Diabetes"},{"key":"B229","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198508083130604","article-title":"In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis","volume":"313","author":"Bottazzo","year":"1985","journal-title":"New Engl J Med"},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.35.11.1215","article-title":"Aberrant expression of HLA-DR antigens by insulin-containing \u03b2-cells in recent-onset type I diabetes mellitus","volume":"35","author":"Foulis","year":"1986","journal-title":"Diabetes"},{"key":"B231","doi-asserted-by":"publisher","DOI":"10.1172\/JCI35449","article-title":"CTLs are targeted to kill \u03b2 cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope","volume":"118","author":"Skowera","year":"2008","journal-title":"J Clin Invest"},{"key":"B232","doi-asserted-by":"publisher","first-page":"988","DOI":"10.2337\/db18-0686","article-title":"HLA class II antigen processing and presentation pathway components demonstrated by transcriptome and protein analyses of islet \u03b2-cells from donors with type 1 diabetes","volume":"68","author":"Russell","year":"2019","journal-title":"Diabetes"},{"key":"B233","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201445378","article-title":"Mouse pancreatic beta cells express MHC class II and stimulate CD4+ T cells to proliferate","volume":"45","author":"Zhao","year":"2015","journal-title":"Eur J Immunol"},{"key":"B234","doi-asserted-by":"publisher","DOI":"10.3109\/08916939008998422","article-title":"HLA DR, DP, DQ induction in human islet \u03b2 cells by the cytokine combination IFN-\u03b3 + TNF-\u03b1","volume":"6","author":"Soldevila","year":"1990","journal-title":"Autoimmunity"},{"key":"B235","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.142.8.2617","article-title":"An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness","volume":"142","author":"Mueller","year":"1989","journal-title":"J Immunol"},{"key":"B236","doi-asserted-by":"publisher","DOI":"10.1006\/jaut.1996.0053","article-title":"Islet-infiltrating T lymphocytes in insulin-dependent diabetic patients express CD80 (B7\u20131) and CD86 (B7\u20132)","volume":"9","author":"Imagawa","year":"1996","journal-title":"J Autoimmun"},{"key":"B237","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.3.326","article-title":"Expression of the co-stimulator molecule B7\u20131 in pancreatic \u03b2-cells accelerates diabetes in the NOD mouse","volume":"44","author":"Wong","year":"1995","journal-title":"Diabetes"},{"key":"B238","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1084\/jem.191.1.97","article-title":"In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes","volume":"191","author":"Wen","year":"2000","journal-title":"J Exp Med"},{"key":"B239","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.2.787","article-title":"Expression of the B7.1 costimulatory molecule on pancreatic \u03b2 Cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes","volume":"173","author":"Havari","year":"2004","journal-title":"J Immunol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMoa012350","article-title":"Effects of insulin in relatives of patients with type 1 diabetes mellitus","volume":"346","year":"2002","journal-title":"New Engl J Med"},{"key":"B241","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.10.2348","article-title":"Pancreatic \u03b2-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes","volume":"27","author":"Harrison","year":"2004","journal-title":"Diabetes Care"},{"key":"B242","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1068","article-title":"Effects of oral insulin in relatives of patients with type 1 diabetes","volume":"28","year":"2005","journal-title":"Diabetes Care"},{"key":"B243","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.7.2126","article-title":"Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9\u201323) peptide","volume":"51","author":"Alleva","year":"2002","journal-title":"Diabetes"},{"key":"B244","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0449","article-title":"No effect of the altered peptide ligand NBI-6024 on \u03b2-cell residual function and insulin needs in new-onset type 1 diabetes","volume":"32","author":"Walter","year":"2009","journal-title":"Diabetes Care"},{"key":"B245","first-page":"1","article-title":"Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes","volume":"9","author":"Ali","year":"2017","journal-title":"Sci Trans Med"},{"key":"B246","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05227-z","article-title":"Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes","volume":"63","author":"Hannelius","year":"2020","journal-title":"Diabetologia"},{"key":"B247","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dmrr.3500","article-title":"Immune response differs between intralymphatic or subcutaneous administration of GAD-alum in individuals with recent onset type 1 diabetes","volume":"38","author":"Dietrich","year":"2022","journal-title":"Diabetes\/Metabolism Res Rev"},{"key":"B248","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2013.1510","article-title":"GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus","volume":"366","author":"Ludvigsson","year":"2012","journal-title":"New Engl J Med"},{"key":"B249","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms10991","article-title":"Type 1 diabetes vaccine candidates promote human Foxp3+ Treg induction in humanized mice","volume":"7","author":"Serr","year":"2016","journal-title":"Nat Commun"},{"key":"B250","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.9.4610","article-title":"A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes","volume":"94","author":"Bergerot","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"B251","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1098-934","article-title":"A plant-based cholera toxin B subunit-insulin fusion protein protects against the developinent of autoimmune diabetes","volume":"16","author":"Arakawa","year":"1998","journal-title":"Nat Biotechnol"},{"key":"B252","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01988.x","article-title":"Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice","volume":"130","author":"Aspord","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"B253","doi-asserted-by":"publisher","DOI":"10.1021\/nn2045246.Multifunctional","article-title":"Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit","volume":"216","author":"Odumosu","year":"2011","journal-title":"Immunobiology"},{"key":"B254","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903931","article-title":"Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice","volume":"184","author":"Vincent","year":"2010","journal-title":"J Immunol"},{"key":"B255","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.3006103.Plasmid-Encoded","article-title":"Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8+ T cells in type 1 diabetes","volume":"5","author":"Roep","year":"2013","journal-title":"Sci Trans Med"},{"key":"B256","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr","article-title":"Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes","volume":"32","author":"Liu","year":"2016","journal-title":"Diabetes\/Metabolism Res Rev"},{"key":"B257","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines8030053","article-title":"Reversal of hyperglycemia and suppression of type 1 diabetes in the NOD mouse with apoptotic DNA immunotherapyTM (ADiTM), ADi-100","volume":"8","author":"Alleva","year":"2020","journal-title":"Biomedicines"},{"key":"B258","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jaut.2018.11.003.A","article-title":"A multi-epitope DNA vaccine enables a broad engagement of diabetogenic T cells for tolerance in Type 1 diabetes","volume":"98","author":"Postigo-Fernandez","year":"2019","journal-title":"J Autoimmun"},{"key":"B259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/9083103","article-title":"Identification of candidate tolerogenic CD8+ T cell epitopes for therapy of type 1 diabetes in the NOD mouse model","volume":"2016","author":"Yu","year":"2016","journal-title":"J Diabetes Res"},{"key":"B260","doi-asserted-by":"publisher","DOI":"10.2337\/db15-1625","article-title":"Reversal of diabetes in NOD Mice by clinical-grade proinsulin and IL-10-secreting Lactococcus lactis in combination with low-dose Anti-CD3 depends on the induction of Foxp3-Positive T Cells","volume":"66","author":"Takiishi","year":"2017","journal-title":"Diabetes"},{"key":"B261","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01103","article-title":"Intestinal Delivery of Proinsulin and IL-10 via Lactococcus lactis Combined With Low-Dose Anti-CD3 Restores Tolerance Outside the Window of Acute Type 1 Diabetes Diagnosis","volume":"11","author":"Cook","year":"2020","journal-title":"Front Immunol"},{"key":"B262","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1236","article-title":"Oral delivery of glutamic acid decarboxylase (GAD)-65 and IL10 by lactococcus lactis reverses diabetes in recent-onset NOD mice","volume":"63","author":"Robert","year":"2014","journal-title":"Diabetes"},{"key":"B263","doi-asserted-by":"publisher","DOI":"10.1021\/acsbiomaterials.9b00332","article-title":"Dual-sized microparticle system for generating suppressive dendritic cells prevents and reverses type 1 diabetes in the nonobese diabetic mouse model","volume":"5","author":"Lewis","year":"2019","journal-title":"ACS Biomaterials Sci Eng"},{"key":"B264","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scisignal.aad0612","article-title":"Tolerogenic nanoparticles inhibit T cell-mediated autoimmunity through SOCS2","volume":"9","author":"Yeste","year":"2016","journal-title":"Sci Signaling"},{"key":"B265","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.03.041","article-title":"Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy","volume":"562","author":"Dul","year":"2019","journal-title":"Int J Pharmaceutics"},{"key":"B266","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2010.03.015","article-title":"Reversal of autoimmunity by boosting memory-like autoregulatory T cells","volume":"32","author":"Tsai","year":"2010","journal-title":"Immunity"},{"key":"B267","doi-asserted-by":"publisher","DOI":"10.1038\/nature16962","article-title":"Expanding antigen-specific regulatory networks to treat autoimmunity","volume":"530","author":"Clemente-Casares","year":"2016","journal-title":"Nature"},{"key":"B268","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.12.010.Tolerogenic","article-title":"Tolerogenic ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells","volume":"89","author":"Prasad","year":"2018","journal-title":"J Autoimmun"},{"key":"B269","doi-asserted-by":"publisher","first-page":"48","DOI":"10.4049\/JIMMUNOL.1900127\/-\/DCSUPPLEMENTAL","article-title":"Nanoparticles containing an insulin\u2013chgA hybrid peptide protect from transfer of autoimmune diabetes by shifting the balance between effector T cells and regulatory T cells","volume":"203","author":"Jamison","year":"2019","journal-title":"J Immunol"},{"key":"B270","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adhm.201800341","article-title":"Prevention of type 1 diabetes with acetalated dextran microparticles containing rapamycin and pancreatic peptide P31","volume":"7","author":"Chen","year":"2018","journal-title":"Advanced Healthcare Materials"},{"key":"B271","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901128","article-title":"Regulatory T cells induced by single-peptide liposome immunotherapy suppress islet-specific T cell responses to multiple antigens and protect from autoimmune diabetes","volume":"204","author":"Bergot","year":"2020","journal-title":"J Immunol"},{"key":"B272","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1705149114","article-title":"Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease","volume":"114","author":"Pishesha","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"B273","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1216353110","article-title":"Engineering antigens for in situ erythrocyte binding induces T-cell deletion","volume":"110","author":"Kontos","year":"2013","journal-title":"Proc Natl Acad Sci"},{"key":"B274","doi-asserted-by":"publisher","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"key":"B275","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.1900014","article-title":"Development and characterization of a preclinical model for the evaluation of CD205-mediated antigen delivery therapeutics in type 1 diabetes","volume":"3","author":"Schloss","year":"2019","journal-title":"ImmunoHorizons"},{"key":"B276","doi-asserted-by":"publisher","DOI":"10.1038\/ni1265","article-title":"Inducing and expanding regulatory T cell populations by foreign antigen","volume":"6","author":"Kretschmer","year":"2005","journal-title":"Nat Immunol"},{"key":"B277","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.105","article-title":"De novo production of antigen-specific suppressor cells in vivo","volume":"1","author":"Kretschmer","year":"2006","journal-title":"Nat Protoc"},{"key":"B278","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4049\/jimmunol.181.10.6923","article-title":"CD8+ CD205+ splenic dendritic cells are specialized to induce Foxp3+ regulatory T cells","volume":"181","author":"Yamazaki","year":"2008","journal-title":"J Immunol"},{"key":"B279","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0802644105","article-title":"Selective delivery of \u03b2 cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice","volume":"105","author":"Mukhopadhaya","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"B280","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1900\/RDS.2010.7.47","article-title":"Dendritic cell-targeted pancreatic \u03b2-cell antigen leads to conversion of self-reactive CD4+ T cells into regulatory T cells and promotes immunotolerance in NOD mice","volume":"7","author":"Petzold","year":"2010","journal-title":"Rev Diabetic Stud"},{"key":"B281","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxt031","article-title":"DEC-205-mediated antigen targeting to steady-state dendritic cells induces deletion of diabetogenic CD8+ T cells independently of PD-1 and PD-L1","volume":"25","author":"Mukherjee","year":"2013","journal-title":"Int Immunol"},{"key":"B282","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1880","article-title":"DCIR2+ cDC2 DCs and Zbtb32 restore CD4+ T-cell tolerance and inhibit diabetes","volume":"64","author":"Price","year":"2015","journal-title":"Diabetes"},{"key":"B283","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30104-2","article-title":"Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide\u2014for type 1 diabetes","volume":"8","author":"Nikolic","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B284","doi-asserted-by":"publisher","DOI":"10.1084\/jem.174.4.791","article-title":"Antigen-driven bystander suppression after oral administration of antigens","volume":"174","author":"Miller","year":"1991","journal-title":"J Exp Med"},{"key":"B285","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"B286","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040180","article-title":"CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes","volume":"199","author":"Tarbell","year":"2004","journal-title":"J Exp Med"},{"key":"B287","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1084\/jem.20061631","article-title":"Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice","volume":"204","author":"Tarbell","year":"2007","journal-title":"J Exp Med"},{"key":"B288","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.5.3053","article-title":"Expansion of functional endogenous antigen-specific CD4+ CD25+ Regulatory T cells from nonobese diabetic mice","volume":"175","author":"Masteller","year":"2005","journal-title":"J Immunol"},{"key":"B289","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2019.05.017","article-title":"Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes","volume":"103","author":"Tenspolde","year":"2019","journal-title":"J Autoimmun"},{"key":"B290","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aad4134.Type","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Trans Med"},{"key":"B291","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn1716","article-title":"Pancreatic islet-specific engineered Tregs exhibit robust antigen-specific and bystander immune suppression in type 1 diabetes models","volume":"14","author":"Yang","year":"2022","journal-title":"Sci Transl Med"},{"key":"B292","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168601","article-title":"Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice","volume":"133","author":"Spanier","year":"2023","journal-title":"J Clin Invest"},{"key":"B293","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz3223","article-title":"Chimeric antigen receptor signaling: Functional consequences and design implications","volume":"6","author":"Lindner","year":"2020","journal-title":"Sci Adv"},{"key":"B294","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheumatol.","article-title":"Outcomes of rituximab therapy in refractory lupus: A meta-analysis","volume":"5","author":"Alshaiki","year":"2018","journal-title":"Eur J Rheumatol"},{"key":"B295","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav1648","article-title":"Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus","volume":"11","author":"Kansal","year":"2019","journal-title":"Sci Trans Med"},{"key":"B296","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"B297","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1016\/j.cell.2023.10.001","article-title":"Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells","volume":"186","author":"Reincke","year":"2023","journal-title":"Cell"},{"key":"B298","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr","article-title":"Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice","volume":"27","author":"Zhang","year":"2011","journal-title":"Diabetes\/Metabolism Res Rev"},{"key":"B299","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.08.004.Chimeric","article-title":"Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes","volume":"96","author":"Zhang","year":"2019","journal-title":"J Autoimmun"},{"key":"B300","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.11.019","article-title":"A TCR-like antibody against a proinsulin-containing fusion peptide ameliorates type 1 diabetes in NOD mice","volume":"534","author":"Matsumoto","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B301","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11804","article-title":"Efficient generation of monoclonal antibodies against peptide in the context of MHCII using magnetic enrichment","volume":"7","author":"Spanier","year":"2016","journal-title":"Nat Commun"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1440045\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T04:49:16Z","timestamp":1723697356000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1440045\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":301,"alternative-id":["10.3389\/fimmu.2024.1440045"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1440045","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]},"article-number":"1440045"}}